Childhood BMI Linked to Increased Risk for Schizophrenia
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 16, 2024 -- Childhood body mass index (BMI) has a direct and enduring effect on the risk for schizophrenia later in life, according to a study published online Sept. 13 in Science Advances.
Pei Xiao, from Beijing Children's Hospital in China, and colleagues used data from the Psychiatric Genomics Consortium and FinnGen study to examine the causal effects of childhood and adulthood BMI on adult psychiatric disorders including Alzheimer disease, anxiety, major depressive disorder, obsessive-compulsive disorder (OCD), and schizophrenia.
The researchers found a significant association for childhood BMI with an increased risk for schizophrenia, while BMI in adulthood was associated with a reduced risk for OCD and schizophrenia. A direct causal effect of childhood BMI on schizophrenia was indicated by multivariable Mendelian randomization analyses, independent of adulthood BMI and lifestyle factors. There was no evidence of causal associations between childhood BMI and other psychiatric outcomes.
"These findings underscore the critical importance of early-life interventions to mitigate the long-term mental health consequences of childhood obesity," the authors write. "Overall, our study provides robust evidence for policymakers and health care professionals to develop targeted interventions aimed at reducing childhood obesity and mitigating its long-term consequences for mental health."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-17 12:00
Read more
- Bird Flu Infection Confirmed in a Pig for First Time in U.S.
- Scientists Successfully Reverse Liver Fibrosis in Mice
- Many Seniors at Risk for Financial Precarity From Cost of Hospital Stay
- Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
- Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with Keytruda (pembrolizumab) After Neoadjuvant Keytruda and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
- ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions